Elite Pharmaceuticals (ELTP) Share-based Compensation (2010 - 2026)
Elite Pharmaceuticals (ELTP) posted Share-based Compensation of $28,476 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 45.6% from $52,329 a year earlier and down 2.4% from the prior quarter.
Elite Pharmaceuticals (ELTP) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Elite Pharmaceuticals was $152,654, down 32.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $176,507, down 22.4% from FY2025.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 68.0% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Share-based Compensation was $227,565 in FY2025 (+42.3%), $159,921 in FY2024 (+306.7%), $39,325 in FY2023 (+174.0%) and $14,353 in FY2022 (+8.9%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Share-based Compensation since fiscal Q1 2024.
- On a year-over-year basis, Share-based Compensation has declined in each of the last four quarters, with an average decline of 8.3% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was fiscal Q2 2024, with growth of 616.1%; the weakest was fiscal Q1 2027, with a decline of 45.6%.
- According to Business Quant data, Share-based Compensation for the three prior fiscal quarters was $29,164 (Q4 2026), $45,096 (Q3 2026) and $49,918 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 28,476.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28,476.00 |
| Mar 31, 2026 | 29,164.00 |
| Dec 31, 2025 | 45,096.00 |
| Sep 30, 2025 | 49,918.00 |
| Jun 30, 2025 | 52,329.00 |
| Mar 31, 2025 | 52,329.00 |
| Dec 31, 2024 | 70,578.00 |
| Sep 30, 2024 | 52,329.00 |
| Jun 30, 2024 | 52,329.00 |
| Mar 31, 2024 | 52,329.00 |
| Dec 31, 2023 | 49,815.00 |
| Sep 30, 2023 | 42,777.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 13,029.00 |
| Sep 30, 2022 | 5,974.00 |
| Jun 30, 2022 | 5,322.00 |
| Mar 31, 2022 | 3,736.00 |
| Dec 31, 2021 | 3,630.00 |
| Sep 30, 2021 | 4,176.00 |
Elite Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();